IHE
iShares U.S. Pharmaceuticals ETF

Price: $183.25
Change: $0.56 (-0.0%)
Last Updated:

Vitals

Brand iShares
Structure ETF
Expense Ratio 0.39%
ETF Home Page Home page
Inception May 01, 2006

Analyst Report

This ETF is one of the options available for investors looking to access the pharmaceutical industry, a sub-sector of health care that has the potential to perform well during periods of consolidation and that may be appealing as a source of capital appreciation over the long run. Given the targeted focus of IHE, this ETF probably isn’t that useful as a core holding in a long-term portfolio; it may, however, be appealing to those looking to apply a tactical tilt towards pharma or implement a sector rotation strategy. IHE is somewhat concentrated, with a relatively shallow basket of holdings and significant weightings afforded to the larger companies in the underlying index. Other options for exposure to pharmaceutical firms include PPH (which is extremely concentrated) and XPH, which is linked to an equal-weighted index and therefore may offer better balance. There is also the “Dynamic” PJP, a more expensive option that may be attractive for those who believe the quant-based methodology adds value.

ETF Database Themes

Asset Class Equity
Asset Class Size Multi-Cap
Asset Class Style Growth
Sector (General) Healthcare
Sector (Specific) Pharmaceutical
Region (General) North America
Region (Specific) U.S.

FactSet Classifications

Segment Equity: U.S. Pharmaceuticals
Category Sector
Focus Health Care
Niche Pharmaceuticals
Strategy Vanilla
Weighting Scheme Market Cap

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $166.99
  • 52 Week Hi $200.99
  • AUM $413.5 M
  • Shares 2.3 M

Historical Trading Data

  • 1 Month Avg. Volume 10,896
  • 3 Month Avg. Volume 11,177

Alternative ETFs in the ETF Database Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $3.1 B 168,085 -5.51%
Largest (AUM) XLV 0.10% $41.9 B 9 M -2.13%
Most Liquid (Volume) XBI 0.35% $7.8 B 11 M -27.65%
Top YTD Performer FTXH 0.60% $42.5 M 12,265 2.26%

Alternative ETFs in the FactSet Equity: U.S. Pharmaceuticals Segment

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest XPH 0.35% $212.3 M 45,782 -8.31%
Largest (AUM) PJP 0.58% $328.6 M 14,965 -2.90%
Most Liquid (Volume) XPH 0.35% $212.3 M 45,782 -8.31%
Top YTD Performer FTXH 0.60% $42.5 M 12,265 2.26%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to its peers.

Holdings Comparison

IHE ETF Database Category Average FactSet Segment Average
Number of Holdings 42 93 35
% of Assets in Top 10 79.62% 43.91% 60.11%
% of Assets in Top 15 88.47% 56.88% 76.04%
% of Assets in Top 50 100.01% 90.95% 100.00%

Size Comparison

IHE ETF Database Category Average FactSet Segment Average
Large (>12.9B) 73.27% 49.79% 58.69%
Mid (>2.7B) 17.95% 23.40% 20.58%
Small (>600M) 8.08% 19.20% 19.44%
Micro (<600M) 0.61% 4.92% 1.13%

IHE Valuation

This section compares the P/E ratio of this ETF to its peers.

IHE
P/E Ratio
22.37
ETF Database Category Average
P/E Ratio
21.65
FactSet Segment Average
P/E Ratio
16.98

IHE Dividend

This section compares the dividend yield of this ETF to its peers.

IHE ETF Database Category Average FactSet Segment Average
Dividend $ 0.83 $ 0.17 $ 0.28
Dividend Date 2021-09-24 N/A N/A
Annual Dividend Rate $ 2.71 $ 0.42 $ 0.96
Annual Dividend Yield 1.39% 0.36% 0.90%

IHE Price and Volume Charts

View charts featuring IHE price and volume data.

IHE Fund Flows Charts

View charts featuring ETF fund flow data.

5 Day Net Flows: 0 1 Month Net Flows: 126.93 K 3 Month Net Flows: -17.82 M 6 Month Net Flows: 31.95 M 1 Year Net Flows: 51.19 M 3 Year Net Flows: 216.56 K 5 Year Net Flows: -232.02 M 10 Year Net Flows: -326.7 M

IHE Price vs Flows AUM Influence Charts

View charts that break down the influence that fund flows and price had on overall assets.